Patents Examined by Deepak R. Ray
  • CRF receptor antagonists and methods relating thereto
    Patent number: 5795905
    Abstract: CRF receptor antagonists are disclosed. Such receptor antagonists are thiadiazole-, pyrimidine-, triazine-, and triazole-containing compounds substituted with both a C3-C14 monocyclic or fused, homoaryl or heteroaryl group and a substituted amine group. The CFR receptor antagonists have utility in the treatment of a variety of disorders, including disorders associated with the hypersecretion of CRF.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: August 18, 1998
    Assignee: Neurocrine Biosciences, Inc.
    Inventors: James R. McCarthy, Yun Feng Xie, Jeffrey P. Whitten, Thomas R. Webb, Chen Chen, John Y. Ramphal